2025-08-29 02:44:45
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
ANG Life Sciences India Ltd H1FY22 consolidated PAT zooms to Rs. 33.77 crore
Posted On : 2021-10-25 20:18:48( TIMEZONE : IST )
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021.
Financial Results (H1 FY21-22)
The company has reported net sales of Rs.215.5458 crores during the 6 months period ended September 30, 2021 as compared to Rs.68.3789 crores during the period ended March 31, 2021.
The company has posted net profit of Rs.33.7779 crores for the 6 months period ended September 30, 2021 as against Rs.1.5254 crores for the 6 months period ended March 31, 2021.
The company has reported EPS of Rs.32.58 for the 6 months period ended September 30, 2021 as compared to Rs.2.943 for the 6 months period ended March 31, 2021.
| Financials | H1 FY21-22 | H2 FY20-21 | % Change |
| Total Income | ₹ 215.5458 crs | ₹ 68.3789 crs |  215.22% |
| Net Profit | ₹ 33.7779 crs | ₹ 1.5254 crs | 2114.36% |
| EPS | ₹ 32.58 | ₹ 2.943 | 1007.03% |
Financial Results (H1 FY21-22) - YoY Comparison
The company has reported net sales of Rs.215.5458 crores during the 6 months period ended September 30, 2021 as compared to Rs.86.5559 crores during the 6 months period ended September 30, 2020.
The company has posted net profit of Rs.33.7779 crores for the 6 months period ended September 30, 2021 as against Rs.5.5021 crores for the 6 months period ended September 30, 2020.
The company has reported EPS of Rs.32.58 for the 6 months period ended September 30, 2021 as compared to Rs.10.62 for the 6 months period ended September 30, 2020.
| Financials | H1 FY21-22 | H1 FY20-21 | % Change |
| Total Income | ₹ 215.5458 crs | ₹ 86.5559 crs | 149.02% |
| Net Profit | ₹ 33.7779 crs | ₹ 5.5021 crs | 513.91% |
| EPS | ₹ 32.58 | ₹ 10.62 | 206.78% |
Shares of ANG Lifesciences India Ltd was last trading in BSE at Rs. 491.90 as compared to the previous close of Rs. 468.50. The total number of shares traded during the day was 16000 in over 5 trades.
The stock hit an intraday high of Rs. 491.90 and intraday low of 491.90. The net turnover during the day was Rs. 7870400.00.
